Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis

Initial clinical trials and surveillance data have shown that the most commonly administered BNT162b2 COVID-19 mRNA vaccine is effective and safe. However, several cases of mRNA vaccine-induced mild to moderate adverse events were recently reported. Here, we report a rare case of myositis after inje...

Descripción completa

Detalles Bibliográficos
Autores principales: Magen, Eli, Mukherjee, Sumit, Bhattacharya, Mahua, Detroja, Rajesh, Merzon, Eugene, Blum, Idan, Livoff, Alejandro, Shlapobersky, Mark, Baum, Gideon, Talisman, Ran, Cherniavsky, Evgenia, Dori, Amir, Frenkel-Morgenstern, Milana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324661/
https://www.ncbi.nlm.nih.gov/pubmed/35891299
http://dx.doi.org/10.3390/vaccines10071135

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9324661/
https://www.ncbi.nlm.nih.gov/pubmed/35891299
http://dx.doi.org/10.3390/vaccines10071135

Ejemplares similares